Sign in

Tori Hall

@victoriahall.bsky.social
153 followers 51 following 2 posts
PostsRepliesMedia
Reposted by Tori Hall
Victor Ferreira, PhD @victorhferreira.bsky.social · 29/09/2025
I couldn’t have asked for a better partner than Dr. Victoria Hall who co-led this work with me. Thanks to the Ajmera Transplant Centre and PSI Foundation for their funding support, to Dr. Lavoie & his team, our UHN colleagues, and to the participants whose generosity made this work possible.
011
Reposted by Tori Hall
Victor Ferreira, PhD @victorhferreira.bsky.social · 29/09/2025
Our first publication addressing RSV vaccination in transplant recipients is now available in Clinical Microbiology and Infection: www.sciencedirect.com/science/arti... We found marginal rates of seroconversion but robust CD4+ T cell responses after a single dose of adjuvanted vaccine.
sciencedirect.com
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: An Interventional Cohort Study
Allogeneic hematopoietic cell transplant (alloHCT) and lung transplant (LT) recipients are at highest risk for severe respiratory syncytial virus (RSV…
121
Tori Hall @victoriahall.bsky.social · 16/10/2025
Pleased to share our article: adj RSV vaccination in high-risk transplant pts - significant NAb and T cell response observed post vaccination. Seroconversion modest in 50% lung transplant and 33% alloHCT. @transplant-uhn.bsky.social @cmijournal.bsky.social www.sciencedirect.com/science/arti...
sciencedirect.com
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study
Allogeneic haematopoietic cell transplant (alloHCT) and lung transplant (LT) recipients are at highest risk for severe respiratory syncytial virus (RS…
010
Reposted by Tori Hall
Ben Teh @benwteh.bsky.social · 04/07/2025
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...
academic.oup.com
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial
In an in-depth immunological analysis of alternate influenza vaccination strategies in high-risk patients receiving therapy for hematological malignancy, p
153
Reposted by Tori Hall
NCICancer @ncicancer.bsky.social · 12/04/2025
A/Prof Ben Teh presenting his and NCIC PhD candidate Dr Tori Halls work on respiratory viruses in people with haem malignancy at #escmidglobal flash poster session. RSV in particular associated with more severe disease
021
Reposted by Tori Hall
NEJM.org @nejm.org · 12/02/2025
Two patients with refractory myeloma who had excellent antitumor responses to cilta-cel CAR T-cell therapy later had T-cell lymphomas that contained the lentivirus construct used to generate the CAR T-cell product. Brief Report on the CARTITUDE-4 trial: nej.md/4gA6G27 #MedSky #Hematology
nej.md
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma | NEJM
We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel (cil...
0176
Reposted by Tori Hall
Isaac Bogoch @isaacbogoch.bsky.social · 05/02/2025
If you care for patients with suspected tuberculosis, this excellent online tool helps assess the risk of active TB disease and potential medication side effects. Link: www.TSTin4D.com From colleagues at McGill. #IDSky #MedSky
26414
Reposted by Tori Hall
Michelle Yong @michyong.bsky.social · 18/01/2025
Congratulations Tori!
011
Reposted by Tori Hall
Peter MacCallum Cancer Centre @petermaccc.bsky.social · 16/01/2025
💉 One flu shot is enough! New research from @benwteh.bsky.social & @victoriahall.bsky.social shows a single flu vaccine dose protects non-transplant blood cancer patients. Simplified care + better vaccine use = big win for vulnerable patients! Learn more: www.petermac.org/about-us/new...
062
Tori Hall @victoriahall.bsky.social · 16/01/2025
Very proud of this hard work & team effort from all involved! Limited benefit of adjuvanted flu 💉 & 2 vs 1 dose in pts w/ MM, CLL or NHL. @ncicancer.bsky.social @petermaccc.bsky.social @benwteh.bsky.social @trubianojason.bsky.social @michyong.bsky.social @nejm.org www.nejm.org/doi/full/10....
nejm.org
Influenza Vaccination Strategies in Patients with Hematologic Cancer | NEJM
In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.
295
Reposted by Tori Hall
Ben Teh @benwteh.bsky.social · 16/01/2025
Practice affirming results from our team @victoriahall.bsky.social @ncicancer.bsky.social - No additional benefit from second influenza vaccine dose/adjuvant vaccines in non-HCT haematology patients. #TxID #IDsky #medsky www.nejm.org/doi/full/10....
nejm.org
Influenza Vaccination Strategies in Patients with Hematologic Cancer | NEJM
In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.
0177
Reposted by Tori Hall
AST IDCOP @ast-idcop.bsky.social · 07/01/2025
Hello to the #IDSky and #TxIDSky community! AST IDCOP is excited to announce our presence on Bluesky. @astinfo.bsky.social
12213